August 2015

Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions

Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions

Atrial septal communications account for approximately 6%–10% of congenital heart defects, with an incidence of 1 in 1,500 live births. The atrial septal defect (ASD) is among the most common acyanotic congenital cardiac lesions, occurring in 0.1% of births and accounting for 30%–40% of clinically important intracardiac shunts in adults. The patent foramen ovale (PFO) is more common and is present in greater than 20%–25% of adults. The clinical syndromes associated with ASD and PFO are extremely variable and represent a significant health burden that spans pediatric and adult medicine, neurology, and surgery. The evaluation of abnormalities of the interatrial septum and their associated syndromes require a standardized, systematic approach to their echocardiographic and Doppler characterization, including the use of transthoracic echocardiographic (TTE), transesophageal echocardiographic (TEE), and intracardiac echocardiographic (ICE) ultrasound, three-dimensional (3D) imaging, Doppler, and transcranial Doppler (TCD) modalities.

AuthorsChair(s)

  • Silvestry, Frank E.
  • Cohen, Meryl S.

AuthorsAuthors

  • Armsby, Laurie B.
  • Burkule, Nitin J.
  • Cohen, Meryl S.
  • Fleishman, Craig E.
  • Hijazi, Ziyad M.
  • Lang, Roberto M.
  • Rome, Jonathan J.
  • Silvestry, Frank E.
  • Wang, Yan

Multi-Language/Translated PDFsTranslated PDFs

Share via
Copy link
Powered by Social Snap